Risk factors for cranial ischemic complications in giant cell arteritis
about
Aspirin as adjunctive treatment for giant cell arteritisAspirin as adjunctive treatment for giant cell arteritisGiant Cell Arteritis and Polymyalgia Rheumatica: 2016 UpdateThe thromboembolic risk in giant cell arteritis: a critical review of the literature.Visual manifestations in giant cell arteritis: trend over 5 decades in a population-based cohortClinical course and management of a consecutive series of patients with "healed temporal arteritis".Giant cell arteritis: a multicenter observational study in Brazil.A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA): Clinical Features and Factors Associated With Severe Ischemic ManifestationsDelays in recognition and management of giant cell arteritis: results from a retrospective audit.Visual loss and other cranial ischaemic complications in giant cell arteritis.Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.The association of vascular risk factors with visual loss in giant cell arteritis.Vertebrobasilar infarction related to giant cell (temporal) arteritis: case report.Polymyalgia rheumatica and the risk of stroke: a three-year follow-up study.Giant Cell (Temporal) Arteritis with Persistent Bilateral Sensorineural Hearing Loss - A Likely Consequence of Delayed Institution of Glucocorticoid Therapy.The Utility of Color Duplex Ultrasonography in the Diagnosis of Giant Cell Arteritis: A Prospective, Masked Study. (An American Ophthalmological Society Thesis).
P2860
Q24194497-1E204775-2A43-473F-8D7F-2205FE99024CQ24198176-46EBA3AE-395E-4688-BAE3-861B9976F7D0Q28070137-6C6843E9-84E4-4B3A-9AD3-75346E31000EQ33745753-71809B24-C7E6-4C16-92BA-7251CF89F3B4Q35200098-D6F3F495-A0D1-4979-B5B0-8D98D0EE0282Q35729917-F3897A38-43EE-4F17-AEF8-4F0A4BE7F070Q36727516-9059275A-309D-4FF8-AFB0-B4E75B9FBEA3Q37205901-8A5150C7-5D13-4234-A82F-AD6276F1E0C6Q37810491-8373B4B8-AF8E-42C8-996F-63ACDD1AACE4Q39416333-D8A2692B-3F23-41F7-8458-D3815300C554Q40041736-3B428308-34E7-4F69-878A-0BD2A6AC4677Q40430511-2505D2B0-8A1E-4EC7-BD74-8AB879A865B2Q41850766-DF884A18-74FC-4CE8-8889-10A89EE0D1ACQ43722950-8931F20D-9A0C-4EF2-97F9-4B26735C9D22Q49552169-98D34C04-F934-4545-AFC4-B86A018AF8D8Q55439546-31E6B51B-7832-4250-82FC-27D5AFC740B8
P2860
Risk factors for cranial ischemic complications in giant cell arteritis
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Risk factors for cranial ischemic complications in giant cell arteritis
@ast
Risk factors for cranial ischemic complications in giant cell arteritis
@en
Risk factors for cranial ischemic complications in giant cell arteritis
@nl
type
label
Risk factors for cranial ischemic complications in giant cell arteritis
@ast
Risk factors for cranial ischemic complications in giant cell arteritis
@en
Risk factors for cranial ischemic complications in giant cell arteritis
@nl
prefLabel
Risk factors for cranial ischemic complications in giant cell arteritis
@ast
Risk factors for cranial ischemic complications in giant cell arteritis
@en
Risk factors for cranial ischemic complications in giant cell arteritis
@nl
P2093
P3181
P1433
P1476
Risk factors for cranial ischemic complications in giant cell arteritis
@en
P2093
Alan Rubinow
Gideon Nesher
Mario Baras
Michal Mates
Moshe Sonnenblick
Ronit Nesher
Yaakov Berkun
P304
P3181
P356
10.1097/01.MD.0000119761.27564.C9
P407
P577
2004-03-01T00:00:00Z